Cytomed Therapeutics LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Chee Kong Choo, a Director and 10% owner of CytoMed Therapeutics Ltd, purchased 200,000 shares of common stock on July 14, 2026 for $1.50 per share.
NASDAQ
Chee Kong Choo, a Director and 10% owner of CytoMed Therapeutics Ltd, reported multiple transactions in common stock on July 14, 2026.
NASDAQ
CytoMed Therapeutics Ltd director Chee Kong Choo reported transactions involving ordinary shares, including acquisitions and disposals.